UBS Group AG - HOMOLOGY MEDICINES INC ownership

HOMOLOGY MEDICINES INC's ticker is FIXX and the CUSIP is 438083107. A total of 53 filers reported holding HOMOLOGY MEDICINES INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS Group AG ownership history of HOMOLOGY MEDICINES INC
ValueSharesWeighting
Q3 2023$16,911
+16.5%
14,454
-11.8%
0.00%
Q2 2023$14,511
+25.0%
16,397
+45.5%
0.00%
Q1 2023$11,608
-33.5%
11,270
-18.6%
0.00%
Q4 2022$17,454
-67.7%
13,853
-58.3%
0.00%
Q3 2022$54,000
-85.6%
33,254
-82.5%
0.00%
Q2 2022$375,000
+406.8%
190,122
+677.7%
0.00%
Q1 2022$74,000
-42.6%
24,448
-30.9%
0.00%
Q4 2021$129,000
+31.6%
35,399
+184.1%
0.00%
Q3 2021$98,000
+226.7%
12,459
+199.2%
0.00%
Q2 2021$30,000
-97.1%
4,164
-96.3%
0.00%
Q1 2021$1,048,000
-11.4%
111,358
+6.3%
0.00%
Q4 2020$1,183,000
+18.3%
104,793
+12.1%
0.00%
Q3 2020$1,000,000
+629.9%
93,500
+957.5%
0.00%
Q1 2020$137,000
+234.1%
8,842
+342.1%
0.00%
Q4 2019$41,000
-95.4%
2,000
-95.9%
0.00%
Q3 2019$882,000
+421.9%
48,708
+465.4%
0.00%
Q2 2019$169,000
+302.4%
8,615
+474.3%
0.00%
Q1 2019$42,000
+68.0%
1,500
+33.8%
0.00%
Q4 2018$25,000
-63.2%
1,121
-62.6%
0.00%
Q3 2018$68,000
+94.3%
2,999
+74.7%
0.00%
Q2 2018$35,0001,7170.00%
Other shareholders
HOMOLOGY MEDICINES INC shareholders Q2 2018
NameSharesValueWeighting ↓
5AM Venture Management, LLC 4,535,919$51,211,00017.25%
Vida Ventures Advisors, LLC 770,845$8,703,0001.79%
AAF Wealth Management, LLC 59,790$675,0000.61%
Vivo Capital, LLC 853,143$9,632,0000.43%
Bellevue Group AG 1,737,122$19,612,0000.22%
PREMIER ASSET MANAGEMENT LLC 77,108$871,0000.18%
Temasek Holdings (Private) Ltd 3,220,293$36,357,0000.16%
American Investment Services, Inc. 36,955$417,0000.13%
Virtus ETF Advisers LLC 24,646$278,0000.12%
FIRST MIDWEST BANK TRUST DIVISION 65,983$745,0000.11%
View complete list of HOMOLOGY MEDICINES INC shareholders